Focusing on the more frequent EGFR activation, reported in approximately 57% of GBM IDH-wildtype, McKinney et al. recently demonstrated that GABP receives signals from EGFR through AMP-activated protein kinase (AMPK). The gene discussed is EGFR; the disease is glioblastoma.